Intra-Cellular Therapies (ITCI:NAS) Fundamental Valuation Report
Intra-Cellular Therapies (ITCI:NAS) Fundamental Valuation Report
Fundamental Valuation Report Intra-Cellular Therapies(ITCI:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$34.43 (USD) 04/30/2021 Weighted Valuation$26.38 (USD) Overall RatingOvervalued by 23.4% Valuation Models Comparables: $26.38 (USD) Valuation Methods This company…
View On WordPress








